Ambry Genetics and PacBio Announce Collaboration to Sequence Up to 7,000 Human Genomes Aimed at Providing Answers for Families Battling Rare Diseases

May 15, 2024

https://www.prnewswire.com/news-releases/ambry-genetics-and-pacbio-announce-collaboration-to-sequence-up-to-7-000-human-genomes-aimed-at-providing-answers-for-families-battling-rare-diseases-302145579.html

Ambry Genetics and PacBio Announce Collaboration to Sequence Up to 7,000 Human Genomes Aimed at Providing Answers for Families Battling Rare Diseases
/PRNewswire/ –Ambry Genetics, a prominent leader in clinical genomic testing and a subsidiary of REALM IDx, Inc., along with PacBio (NASDAQ:PACB), a leading…
https://www.prnewswire.com/news-releases/ambry-genetics-and-pacbio-announce-collaboration-to-sequence-up-to-7-000-human-genomes-aimed-at-providing-answers-for-families-battling-rare-diseases-302145579.html

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.